معرفی
Prof. Dr. Miquel Serra-Burriel is a full Professor at the University of Zurich, based in the Institute of Epidemiology, Biostatistics and Prevention (EBPI). His work bridges population health sciences with advanced biostatistical and health-economic methods.
Research Focus:
- Hepatology & liver-disease epidemiology, including steatotic liver disease and cirrhosis
- Cancer screening programmes (colorectal, lung, liver)
- Pharmacoepidemiology and health-technology assessment
- Causal machine-learning approaches to personalised treatment effects
- Health-economics of chronic diseases and drug pricing across the US, EU and Switzerland
Across more than 50 recent publications (2022-2025) he consistently applies rigorous epidemiological designs—randomised trials, cohort studies, systematic reviews and target-trial emulations—to answer pressing clinical and public-health questions. A dominant theme is the translation of evidence into policy, exemplified by comparative analyses of regulatory timelines, reimbursement delays, drug shortages and pricing trajectories in high-income countries.
Scientific Awards & Recognition:
No specific awards were mentioned in the supplied text.
Funding & Collaborative Networks:
While explicit grant identifiers are absent, the breadth of multicentre and multinational studies (e.g., Swiss-AF, COLONPREV, LiverScreen, EASL–Lancet Liver Commission) indicates substantial competitive funding and extensive collaboration with clinical, regulatory and academic partners across Europe and North America.
Laboratories & Teams:
Prof. Serra-Burriel leads research activities within the EBPI, working closely with interdisciplinary teams spanning biostatistics, health economics, hepatology, cardiology and data science.
